Costanzi, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 229
EU - Europa 187
AS - Asia 93
SA - Sud America 9
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 527
Nazione #
US - Stati Uniti d'America 228
SE - Svezia 55
DE - Germania 42
CN - Cina 38
FR - Francia 32
SG - Singapore 27
PL - Polonia 12
IN - India 10
IE - Irlanda 9
BR - Brasile 8
ID - Indonesia 8
IT - Italia 8
UA - Ucraina 8
CI - Costa d'Avorio 6
GB - Regno Unito 6
FI - Finlandia 4
RU - Federazione Russa 4
BE - Belgio 3
TR - Turchia 3
EU - Europa 2
HK - Hong Kong 2
IR - Iran 2
NL - Olanda 2
AU - Australia 1
BD - Bangladesh 1
CA - Canada 1
EC - Ecuador 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
PK - Pakistan 1
RO - Romania 1
Totale 527
Città #
Chandler 71
Singapore 18
Ashburn 15
New York 14
Kraków 12
Nanjing 10
Dublin 9
Jakarta 8
San Mateo 8
Ann Arbor 7
Marseille 7
Wilmington 7
Abidjan 6
Bremen 6
Jacksonville 6
Princeton 6
Boston 5
Dearborn 5
Los Angeles 5
Beijing 3
Brussels 3
Cattolica 3
Düsseldorf 3
Fairfield 3
Helsinki 3
Izmir 3
Lauterbourg 3
Portsmouth 3
Seattle 3
Augusta 2
Changchun 2
Frankfurt am Main 2
Hong Kong 2
Moscow 2
North Bergen 2
Rome 2
Shenyang 2
Woodbridge 2
Zhengzhou 2
Alta Floresta 1
Belo Horizonte 1
Chicago 1
Dongguan 1
Ergolding 1
Falkenstein 1
Guangzhou 1
Handan 1
Harbin 1
Houston 1
Islamabad 1
Juiz de Fora 1
Kemerovo 1
Kish 1
Laojunmiao 1
Lawrence 1
Limeira 1
Luhansk 1
Mirassol 1
Mogi das Cruzes 1
Mountain View 1
Munich 1
Nanchang 1
Nanning 1
Newark 1
Nuremberg 1
Oslo 1
Penrith 1
Quito 1
Redwood City 1
San Francisco 1
Stockholm 1
São Paulo 1
Tapejara 1
Tianjin 1
Toronto 1
Vientiane 1
Totale 312
Nome #
A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy. 143
Defective activation of the MAPK/ERK pathway, leading to PARP1 and DNMT1 dysregulation, is a common defect in IgA nephropathy and Henoch-Schönlein purpura 77
Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity 75
Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: A randomized controlled trial 69
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 61
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 56
Deterioration in Clinical Status Is Not Enough to Suspend Eculizumab: A Genetic Complement-Mediated Atypical Hemolytic Uremic Syndrome Case Report 54
Totale 535
Categoria #
all - tutte 2.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.682


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 0 0 0 0 0 9 1
2020/202116 0 2 0 1 1 0 5 0 2 1 2 2
2021/202268 6 1 3 1 5 2 0 13 4 4 13 16
2022/2023181 26 22 12 34 7 26 15 13 19 0 5 2
2023/202462 3 14 1 7 0 8 6 1 0 4 9 9
2024/202585 1 1 11 6 11 7 2 8 16 19 3 0
Totale 535